These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16477587)

  • 81. Escitalopram-induced subclinical hypothyroidism. A case report.
    Mazokopakis EE; Karefilakis CM; Starakis IK
    Hormones (Athens); 2012; 11(1):101-3. PubMed ID: 22450350
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Are newer antidepressants really "better tolerated"?
    Robinson MJ
    Can J Psychiatry; 2001 Apr; 46(3):286-7. PubMed ID: 11320685
    [No Abstract]   [Full Text] [Related]  

  • 83. Combination therapy of lamotrigine and escitalopram may cause myoclonus.
    Rosenhagen MC; Schmidt U; Weber F; Steiger A
    J Clin Psychopharmacol; 2006 Jun; 26(3):346-7. PubMed ID: 16702909
    [No Abstract]   [Full Text] [Related]  

  • 84. The depressions of Alzheimer's disease: sorting, pharmacotherapy, and clinical advice.
    Knesper DJ
    J Geriatr Psychiatry Neurol; 1995 Oct; 8 Suppl 1():S40-51. PubMed ID: 8561843
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Post-stroke depression, not to be underestimated.
    Hachinski V
    Lancet; 1999 May; 353(9166):1728. PubMed ID: 10347982
    [No Abstract]   [Full Text] [Related]  

  • 86. [Affective disorders in Alzheimer's disease].
    Bovier P
    Rev Med Suisse Romande; 1997 Sep; 117(9):651-3. PubMed ID: 9411679
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Characteristics of Escitalopram Discontinuation Syndrome: A Preliminary Study.
    Yasui-Furukori N; Hashimoto K; Tsuchimine S; Tomita T; Sugawara N; Ishioka M; Nakamura K
    Clin Neuropharmacol; 2016; 39(3):125-7. PubMed ID: 27171568
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Depression in Alzheimer's disease: heterogeneity and related issues.
    Lee HB; Lyketsos CG
    Biol Psychiatry; 2003 Aug; 54(3):353-62. PubMed ID: 12893110
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Clinical efficacy of escitalopram in patients with ischemic heart disease and comorbid depression].
    Pogosova GV; Koltunov IE; Karpova AV; Eliseeva NA; Sapunova ID
    Kardiologiia; 2009; 49(3):4-8. PubMed ID: 19257858
    [No Abstract]   [Full Text] [Related]  

  • 90. Interferon-induced depression treated with citalopram.
    Farah A
    J Clin Psychiatry; 2002 Feb; 63(2):166-7. PubMed ID: 11874221
    [No Abstract]   [Full Text] [Related]  

  • 91. [Depressive disorders in patients after stroke].
    Gusev EI; Bogolepova AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; Suppl 22():10-5. PubMed ID: 19431241
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The Efficacy of Sertraline, Escitalopram, and Nicergoline in the Treatment of Depression and Apathy in Alzheimer's Disease: The Okayama Depression and Apathy Project (ODAP).
    Takemoto M; Ohta Y; Hishikawa N; Yamashita T; Nomura E; Tsunoda K; Sasaki R; Tadokoro K; Matsumoto N; Omote Y; Abe K
    J Alzheimers Dis; 2020; 76(2):769-772. PubMed ID: 32568205
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Beyond symptoms: social functioning and the new antidepressants.
    Weissman MM
    J Psychopharmacol; 1997; 11(4 Suppl):S5-8. PubMed ID: 9438227
    [No Abstract]   [Full Text] [Related]  

  • 94. Effects of Citalopram on Neuropsychiatric Symptoms in Alzheimer's Dementia: Evidence From the CitAD Study.
    Leonpacher AK; Peters ME; Drye LT; Makino KM; Newell JA; Devanand DP; Frangakis C; Munro CA; Mintzer JE; Pollock BG; Rosenberg PB; Schneider LS; Shade DM; Weintraub D; Yesavage J; Lyketsos CG; Porsteinsson AP;
    Am J Psychiatry; 2016 May; 173(5):473-80. PubMed ID: 27032628
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Treatment of depression in elderly patients with and without dementia disorders.
    Gottfries CG; Karlsson I; Nyth AL
    Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 5():55-64. PubMed ID: 1431023
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Escitalopram and QTc prolongation.
    Hasnain M; Howland RH; Vieweg WV
    J Psychiatry Neurosci; 2013 Jul; 38(4):E11. PubMed ID: 23791140
    [No Abstract]   [Full Text] [Related]  

  • 97. Neuropsychiatric aspects of failure to thrive in late life.
    Katz IR; DiFilippo S
    Clin Geriatr Med; 1997 Nov; 13(4):623-38. PubMed ID: 9354745
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Depression in Alzheimer's disease: overview and treatment.
    Lyketsos CG; Olin J
    Biol Psychiatry; 2002 Aug; 52(3):243-52. PubMed ID: 12182930
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Playing with fire? Depression and drug therapy].
    Kovács G
    Neuropsychopharmacol Hung; 2004 Mar; 6(1):40-1; author reply 41-3. PubMed ID: 15125315
    [No Abstract]   [Full Text] [Related]  

  • 100. The citalopram CIT-MD-18 pediatric depression trial: Deconstruction of medical ghostwriting, data mischaracterisation and academic malfeasance.
    Jureidini JN; Amsterdam JD; McHenry LB
    Int J Risk Saf Med; 2016 Mar; 28(1):33-43. PubMed ID: 27176755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.